MACHINE LEARNING METHOD FOR PROTEIN MODELLING TO DESIGN ENGINEERED PEPTIDES

Patent №

US 11,545,238

Granted

2023-01-03

Filed 2020

Owner

RUBRYC THERAPEUTICS, INC.

+1 more

Lab

AI components

6

ml · nlp · vision · planning · evo · hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

17108958

Provided herein are methods for design of engineered polypeptides that recapitulate molecular structure features of a predetermined portion of a reference protein structure, e.g., an antibody epitope or a protein binding site. A Machine Learning (ML) model is trained by labeling blueprint records generated from a reference target structure with scores calculated based on computational protein modeling of polypeptide structures generated by the blueprint records. The method may include training an ML model based on a first set of blueprint records, or representations thereof, and a first set of scores, each blueprint record from the first set of blueprint records associated with each score from the first set of scores. After the training, the machine learning model may be executed to generate a second set of blueprint records. A set of engineered polypeptides are then generated based on the second set of blueprint records.

Machine learningNatural languageVisionPlanningEvolutionary computationAI hardwareG01N 33/6845G16B 40/20C07K 14/00C07K 14/001G06N 3/0464G06N 3/0475G06N 3/09G06N 5/01+11 more

AI classification

Machine learning1.00
Natural language1.00
AI hardware1.00
Planning1.00
Evolutionary computation0.97
Vision0.97
Knowledge representation0.47
Speech0.00

Ownership

RUBRYC THERAPEUTICS, INC.

assignment · 568670001

IBIO, INC.

assignment · 612560960

Assignors

GREVING, MATTHEW P., HAUSER, KEVIN E., TAGUCHI, ALEXANDER T.

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC